Macrophage death and lipid metabolism in atherosclerosis
Macrophage death and lipid metabolism in atherosclerosis
批准号:
6325963
负责人:
Ira A Tabas
金额:
$26.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2001-06-30
关键词:
CD95 molecule apolipoprotein E apoptosis atherosclerosis blood lipoprotein metabolism cholesterol genetically modified animals laboratory mouse macrophage molecular pathology necrosis nucleotidyltransferase phosphatidylcholine sterol acyltransferase phosphatidylcholines tissue /cell culture transport proteins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Macrophage (Mphi) death is an important feature of atherosclerotic lesions, yet there are still uncertainties about the physiological consequences of this event. Our laboratory has shown that free cholesterol (FC) loading of cultured can be prevented by FC-induced up-regulation of phosphatidylcholine (PC) biosynthesis and by blockage of FC transport to peripheral cellular sites (e.g., plasma membrane & mitochondria). In this context, the overall objective of this proposal is to test specific hypotheses regarding Mphi death in atherosclerosis using mice in which lipid metabolic and death-signaling pathways have been genetically manipulated. The hypotheses are that Mphi may (a) be protective by limiting the number of Mphi's during lesion development and perhaps by "safely" disposing of dying Mphi's in advanced lesions; and/or (b) contribute to lipid core development by promoting the release of harmful molecules from dying Mphi's. Protective effects may occur when Mphi's die by "apoptosis", whereas harmful effects may occur when Mphi's die by more "necrotic"-like processes. In Aim I, we will use apolipoprotein E knockout (atherosclerotic) mice with Mphi-specific alterations in PC biosynthesis (via; genetic manipulation of CTP: phosphocholine cytidylylyltransferase) or with defective FC transport to peripheral cellular sites (Niemann-Pick C mice). The goal will be to test the role of PC and FC metabolism in Mphi death in vivo and to evaluate, in the context of our hypotheses, the consequences of altered Mphi death on atherogenesis and lipid core development. In Aim II, we will specifically examine mouse models in which Mphi apoptosis should be blocked. In view of preliminary data showing the FC-mediated apoptosis is prevented in Mphi's lacking the Fas death receptor, a major focus will be on mice in which Fas is absent in Mphi's. The role of the Fas pathway in Mphi death caused by older inducers, such as oxidized lipoproteins and growth factor withdrawal, will also be explored. Furthermore, given the key role of bcl- 2 family proteins in certain types of Fas-mediated apoptosis as well as in death due to other causes, mice whose Mphi's over-express the anti- apoptotic proteins Bcl-2 and Bcl-xL will be examined for atherogenesis and lipid core development. Blockage of lesional Mphi apoptosis may, according the above-state hypothesis, adversely affect atherogenesis in necrotic-like changes are left uninhibited. In summary, this project should help elucidate lipid-based mechanisms and physiologic consequences of Mphi death in atherogenesis and lipid core development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
-
批准号:9889165
-
项目类别:
-
资助金额:$97.9万
-
财政年份:2019
-
负责人:Ira A Tabas
-
依托单位:
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
-
批准号:10339421
-
项目类别:
-
资助金额:$97.13万
-
财政年份:2019
-
负责人:Ira A Tabas
-
依托单位:
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
-
批准号:10565956
-
项目类别:
-
资助金额:$97.13万
-
财政年份:2019
-
负责人:Ira A Tabas
-
依托单位:
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques
-
批准号:10112953
-
项目类别:
-
资助金额:$97.14万
-
财政年份:2019
-
负责人:Ira A Tabas
-
依托单位:
"MerTK Cleavage and Signaling in Atherosclerosis"
-
批准号:9120607
-
项目类别:
-
资助金额:$50.81万
-
财政年份:2016
-
负责人:Ira A Tabas
-
依托单位:
Autophagy in Advanced Atherosclerosis
-
批准号:8023974
-
项目类别:
-
资助金额:$46.51万
-
财政年份:2011
-
负责人:Ira A Tabas
-
依托单位:
Autophagy in Advanced Atherosclerosis
-
批准号:8383465
-
项目类别:
-
资助金额:$44.28万
-
财政年份:2011
-
负责人:Ira A Tabas
-
依托单位:
Autophagy in Advanced Atherosclerosis
-
批准号:8575545
-
项目类别:
-
资助金额:$45.58万
-
财政年份:2011
-
负责人:Ira A Tabas
-
依托单位:
Autophagy in Advanced Atherosclerosis
-
批准号:8208979
-
项目类别:
-
资助金额:$46.51万
-
财政年份:2011
-
负责人:Ira A Tabas
-
依托单位:
Mechanisms of Defective Efferocytosis in Atherosclerosis
-
批准号:8389888
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2011
-
负责人:Ira A Tabas
-
依托单位:
Mechanisms of Defective Efferocytosis in Atherosclerosis
-
批准号:8575547
-
项目类别:
-
资助金额:$39.2万
-
财政年份:2011
-
负责人:Ira A Tabas
-
依托单位:
ROLE OF CAMKII IN HEPATIC GLUCONEOGENESIS
-
批准号:8365867
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2011
-
负责人:Ira A Tabas
-
依托单位:
Mechanisms of Defective Efferocytosis in Atherosclerosis
-
批准号:8233659
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2011
-
负责人:Ira A Tabas
-
依托单位:
2010 Lipoprotein Metabolism GRC
-
批准号:7905516
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2010
-
负责人:Ira A Tabas
-
依托单位:
CaMKII/MK2 Signaling in Cardiometabolic Disease
-
批准号:10197189
-
项目类别:
-
资助金额:$55.01万
-
财政年份:2007
-
负责人:Ira A Tabas
-
依托单位:
Mechanisms of Atherogenesis in Insulin Resistance
-
批准号:7299226
-
项目类别:
-
资助金额:$216.01万
-
财政年份:2007
-
负责人:Ira A Tabas
-
依托单位:
Administrative Core
-
批准号:8460256
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2007
-
负责人:Ira A Tabas
-
依托单位:
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
-
批准号:8606760
-
项目类别:
-
资助金额:$53.25万
-
财政年份:2007
-
负责人:Ira A Tabas
-
依托单位:
Administrative Core
-
批准号:10428374
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2007
-
负责人:Ira A Tabas
-
依托单位:
CaMKII/MK2 Signaling in Cardiometabolic Disease
-
批准号:10428376
-
项目类别:
-
资助金额:$55.01万
-
财政年份:2007
-
负责人:Ira A Tabas
-
依托单位:
海外基金